Xia, Q., Xun, Y., Lu, J., Lu, Y., Yang, Y., Zhou, P., . . . Wang, S. (2020). Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID‐19. Cell Prolif.

Xia, Qi‐Dong, Yang Xun, Jun‐Lin Lu, Yu‐Chao Lu, Yuan‐Yuan Yang, Peng Zhou, Jia Hu, Cong Li, và Shao‐Gang Wang. "Network Pharmacology and Molecular Docking Analyses On Lianhua Qingwen Capsule Indicate Akt1 Is a Potential Target to Treat and Prevent COVID‐19." Cell Prolif 2020.

Xia, Qi‐Dong, et al. "Network Pharmacology and Molecular Docking Analyses On Lianhua Qingwen Capsule Indicate Akt1 Is a Potential Target to Treat and Prevent COVID‐19." Cell Prolif 2020.